; (2) opportunities that exist to make additional progress in reducing the impact of sleep and circadian health disorders in such communities and populations; (3) challenges that may impede such additional progress; and (4) Federal funding necessary to achieve substantial reductions in sleep and circadian health disorders in racial and ethnic minority communities. K Sickle Cell Disease Research, Surveillance, Prevention, and Treatment 796. Short title This subtitle may be cited as the Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 . 796A. Sickle cell disease research Part P of title III of the Public Health Service Act ( 42 U.S.C. 280g et seq.), as amended by section 774, is further amended by adding at the end the following: 399V–11. National sickle cell disease research, surveillance, prevention, and treatment program (a) Research The Secretary may conduct or support research to expand the understanding of the cause of, and to find a cure for, sickle cell disease. . 796B. Sickle cell disease surveillance Section 399V–11 of the Public Health Service Act, as added by section 796A, is amended by adding at the end the following: (b) Surveillance (1) Grants The Secretary may, for each fiscal year for which appropriations are available to carry out this subsection, make grants— (A) to conduct surveillance and maintain data on the prevalence and distribution of sickle cell disease and its associated health outcomes, complications, and treatments; (B) to conduct public health initiatives with respect to sickle cell disease, including— (i) increasing efforts to improve access to, and receipt of, high-quality sickle cell disease-related health care, including the use of treatments approved under section 505 of the Federal Food, Drug, and Cosmetic Act or licensed under section 351 of this Act